Literature DB >> 7236495

Coumarin or warfarin treatment of mice does not increase the microbicidal or tumoricidal capacities of macrophages.

G A Filice, J S Remington.   

Abstract

Benzopyrones have been shown to affect several functions of macrophages. We examined the effects of two benzopyrones, coumarin and warfarin, on the capacity of mouse macrophages to inhibit microorganisms and tumour target cells. Mice were treated with daily i.v. doses of either drug. Then the mice were challenged with lethal doses of Toxoplasma gondii or peritoneal macrophages from these mice were challenged in vitro with T. gondii or tumour target cells Survival of coumarin or warfarin-treated mice challenged with T. gondii was similar to that of control mice. Multiplication of T gondii and growth of tumour target cells were similar in preparations of macrophages from coumarin-treated, warfarin-treated, or control mice and were inhibited in preparations of activated macrophages from Corynebacterium parvum-treated mice that served as positive controls. Under our experimental conditions, benzopyrones did not activate mouse macrophages.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7236495      PMCID: PMC2041660     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  17 in total

1.  Reticuloendothelial system and anticoagulant therapy. Studies with radioactive colloidal gold.

Authors:  E ADLERCREUTZ; T PETTERSSON
Journal:  Lancet       Date:  1963-03-02       Impact factor: 79.321

2.  The use of a tissue tonometer as a diagnostic aid in extremity lymphoedema: a determination of its conservative treatment with benzo-pyrones.

Authors:  N B Piller; L Clodius
Journal:  Lymphology       Date:  1976-12       Impact factor: 1.286

3.  An in vitro demonstration of proteolysis by macrophages and its increase with coumarin.

Authors:  T Bolton; J R Casley-Smith
Journal:  Experientia       Date:  1975-03-15

4.  The use of killed vaccines in immunization against an intracellular parasite: Toxoplasma gondii.

Authors:  J L Krahenbuhl; J Ruskin; J S Remington
Journal:  J Immunol       Date:  1972-02       Impact factor: 5.422

5.  Studies on the specificity of killing of intracellular pathogens by macrophages.

Authors:  R McLeod; J S Remington
Journal:  Cell Immunol       Date:  1977-11       Impact factor: 4.868

6.  The role of activated macrophages in specific and nonspecific cytostasis of tumor cells.

Authors:  J L Krahenbuhl; J S Remington
Journal:  J Immunol       Date:  1974-08       Impact factor: 5.422

7.  The ineffectiveness of coumarin treatment on thermal oedema of macrophage-free rats.

Authors:  N B Piller
Journal:  Br J Exp Pathol       Date:  1976-04

8.  The value of multifactorial screening for anti-inflammatory activity as shown by coumarin.

Authors:  C J Dunn; M S Koh; D A Willoughby; J P Giroud
Journal:  J Pathol       Date:  1977-08       Impact factor: 7.996

9.  An integration of the modes of action of coumarin. An explanation of its effectiveness as a therapy for thermally injured tissue.

Authors:  N B Piller
Journal:  Arzneimittelforschung       Date:  1977

10.  Effects of Corynebacterium parvum treatment and Toxoplasma gondii infection on macrophage-mediated cytostasis of tumour target cells.

Authors:  J L Krahenbuhl; L H Lambert; J S Remington
Journal:  Immunology       Date:  1976-12       Impact factor: 7.397

View more
  2 in total

1.  Prevention of tumorigenesis of oncogene-transformed rat fibroblasts with DNA site inhibitors of poly(ADP ribose) polymerase.

Authors:  A Tseng; W M Lee; E B Jakobovits; E Kirsten; A Hakam; J McLick; K Buki; E Kun
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

2.  Antimicrobial properties of Kupffer cells.

Authors:  G A Filice
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.